Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/role-of-positron-emission-tomography-as-a-biologic-marker-in-the-Tg484PF30j
References (14)
-
P. Nestor, N. Graham, T. Fryer, Guy Williams, K. Patterson, J. Hodges (2003)
Progressive non-fluent aphasia is associated with hypometabolism centred on the left anterior insula.Brain : a journal of neurology, 126 Pt 11
-
M. Mesulam, E. Rogalski, C. Wieneke, R. Hurley, C. Geula, E. Bigio, C. Thompson, S. Weintraub (2014)
Primary progressive aphasia and the evolving neurology of the language networkNature Reviews Neurology, 10
-
A. Villarejo-Galende, S. Llamas-Velasco, A. Gómez-Grande, V. Puertas-Martín, I. Contador, P. Sarandeses, M. González-Sánchez, R. Trincado, P. Pilkington, S. Ruiz-Solís, D. Pérez-Martínez, A. Martín (2016)
Amyloid pet in primary progressive aphasia: case series and systematic review of the literatureJournal of Neurology, 264
-
M. Grossman (2010)
Primary progressive aphasia: clinicopathological correlationsNature Reviews Neurology, 6
-
S. Ince, E. Eroğlu, A. Karacalioglu, O. Emer, E. Alagoz (2015)
18F-FDG PET/CT findings in a case of a semantic variant of primary progressive aphasia.Hellenic journal of nuclear medicine, 18 2
-
M. Mesulam, S. Weintraub, T. Parrish, D. Gitelman (2005)
Primary progressive aphasia: Reversed asymmetry of atrophy and right hemisphere language dominanceNeurology, 64
-
M. Grossman (2012)
The non-fluent/agrammatic variant of primary progressive aphasiaThe Lancet Neurology, 11
-
M. Gorno-Tempini, M. Gorno-Tempini, A. Hillis, S. Weintraub, A. Kertesz, Mario Mendez, S. Cappa, J. Ogar, J. Rohrer, S. Black, B. Boeve, F. Manes, N. Dronkers, Rik Vandenberghe, K. Rascovsky, K. Patterson, B. Miller, D. Knopman, J. Hodges, M. Mesulam, M. Grossman (2011)
Classification of primary progressive aphasia and its variantsNeurology, 76
-
H. Kirshner (2014)
Frontotemporal dementia and primary progressive aphasia, a reviewNeuropsychiatric Disease and Treatment, 10
-
F. Niccolini, M. Politis (2016)
A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonismEuropean Journal of Nuclear Medicine and Molecular Imaging, 43
-
A. Kertesz, M. Harciarek (2014)
Primary progressive aphasia.Scandinavian journal of psychology, 55 3
-
M. Mesulam, C. Wieneke, C. Thompson, E. Rogalski, S. Weintraub (2012)
Quantitative classification of primary progressive aphasia at early and mild impairment stages.Brain : a journal of neurology, 135 Pt 5
-
G. Rabinovici, W. Jagust, A. Furst, J. Ogar, C. Racine, E. Mormino, J. O’Neil, R. Lal, N. Dronkers, B. Miller, M. Gorno-Tempini (2008)
Aβ amyloid and glucose metabolism in three variants of primary progressive aphasiaAnnals of Neurology, 64
-
R. Vandenberghe (2016)
Classification of the primary progressive aphasias: principles and review of progress since 2011Alzheimer's Research & Therapy, 8
- Publisher
- Springer Journals
- Copyright
- Copyright © 2018 by Korean Society of Nuclear Medicine
- Subject
- Medicine & Public Health; Nuclear Medicine; Imaging / Radiology; Orthopedics; Cardiology; Oncology
- ISSN
- 1869-3474
- eISSN
- 1869-3482
- DOI
- 10.1007/s13139-018-0538-5
- Publisher site
- See Article on Publisher Site
Abstract
Primary progressive aphasia (PPA) is a heterogenous neurodegenerative disorder characterized by declining language and speech ability. Various underlying neuropathologies can induce PPA, and the disorder is divided into three subtypes—progressive non-fluent aphasia, semantic variant aphasia, and logopenic aphasia—according to clinical features. Accurate disease classification and prediction of underlying diseases are necessary for appropriate treatment, but proper use of imaging tests is important because clinical information alone often makes it difficult to make accurate decisions. Because there is a characteristic metabolic pattern according to the subtypes, F-18 fluorodeoxyglucose positron emission tomography (PET) can indicate subtype classification. In addition, PET studies for imaging amyloid or dopamine transporters play an important role in demonstrating underlying disease. The present case showed that PET imaging studies are useful in diagnosis and could be used as a biomarker in PPA.
Journal
Nuclear Medicine and Molecular Imaging – Springer Journals
Published: Aug 8, 2018